Dillione Janet 4

What Happened
Director Janet Dillione reported the sale of 10,000 shares of CorMedix, Inc. (CRMD) on January 21, 2026. The filing reports a weighted average sale price of $6.88 per share for total proceeds of approximately $68,800. The transaction is coded as a sale (S) and was executed in multiple trades at prices ranging from $6.85 to $6.90 (footnote F1).

Key Details

• Transaction date: 2026-01-21 (reported on Form 4 filed 2026-01-22).
• Price: Weighted average $6.88; individual trades ranged $6.85–$6.90 (per filing footnote).
• Shares sold: 10,000; proceeds ≈ $68,800.
• Shares owned after transaction: Not specified in the provided Form 4.
• Footnote: F1 confirms multiple trades and offers provision to provide exact trade-by-trade details on request.
• Remarks: Exhibit 24.1 (Power of Attorney) included.
• Filing timeliness: Reported the next day (appears timely; no late filing indicated).

Context
A director sale is a disposition of shares and does not by itself indicate the insider’s view of the company’s prospects — such sales can be for liquidity or portfolio reasons. Purchases generally carry stronger signals of insider confidence; this filing documents a routine open‑market sale.